Bank of New York Mellon’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.76M | Sell |
325,808
-27,462
| -8% | -$233K | ﹤0.01% | 2582 |
|
|
2025
Q1 | $2.84M | Sell |
353,270
-1,908
| -0.5% | -$15.3K | ﹤0.01% | 2497 |
|
|
2024
Q4 | $3.19M | Sell |
355,178
-5,425
| -2% | -$48.7K | ﹤0.01% | 2509 |
|
|
2024
Q3 | $2.64M | Sell |
360,603
-128,118
| -26% | -$939K | ﹤0.01% | 2611 |
|
|
2024
Q2 | $2.79M | Buy |
488,721
+77,510
| +19% | +$443K | ﹤0.01% | 2610 |
|
|
2024
Q1 | $2.06M | Buy |
411,211
+17,573
| +4% | +$88K | ﹤0.01% | 2747 |
|
|
2023
Q4 | $3.54M | Sell |
393,638
-4,284
| -1% | -$38.5K | ﹤0.01% | 2540 |
|
|
2023
Q3 | $3.09M | Sell |
397,922
-4,512
| -1% | -$35.1K | ﹤0.01% | 2562 |
|
|
2023
Q2 | $3.9M | Buy |
402,434
+3,869
| +1% | +$37.5K | ﹤0.01% | 2462 |
|
|
2023
Q1 | $4.37M | Sell |
398,565
-5,269
| -1% | -$57.7K | ﹤0.01% | 2379 |
|
|
2022
Q4 | $1.74M | Sell |
403,834
-3,517
| -0.9% | -$15.2K | ﹤0.01% | 2923 |
|
|
2022
Q3 | $3.06M | Buy |
407,351
+35,854
| +10% | +$270K | ﹤0.01% | 2571 |
|
|
2022
Q2 | $3.73M | Buy |
+371,497
| New | +$3.73M | ﹤0.01% | 2478 |
|
|
2021
Q3 | – | Sell |
-14,170
| Closed | -$183K | – | 4516 |
|
|
2021
Q2 | $183K | Sell |
14,170
-38,030
| -73% | -$491K | ﹤0.01% | 4112 |
|
|
2021
Q1 | $678K | Sell |
52,200
-6,681
| -11% | -$86.8K | ﹤0.01% | 3529 |
|
|
2020
Q4 | $814K | Buy |
+58,881
| New | +$814K | ﹤0.01% | 3364 |
|
|
2018
Q1 | – | Sell |
-11,657
| Closed | -$52K | – | 4299 |
|
|
2017
Q4 | $52K | Buy |
+11,657
| New | +$52K | ﹤0.01% | 4188 |
|
|
2017
Q3 | – | Sell |
-81,950
| Closed | -$502K | – | 4266 |
|
|
2017
Q2 | $502K | Buy |
81,950
+931
| +1% | +$5.7K | ﹤0.01% | 3601 |
|
|
2017
Q1 | $595K | Buy |
+81,019
| New | +$595K | ﹤0.01% | 3483 |
|